AGN194204 (IRX4204) is a selective retinoid X receptor (RXR) agonist with anti-inflammatory and anticancer activities; it inhibits lipopolysaccharide- and tumor necrosis factor-α-induced release of nitric oxide and interleukin-6, and prevents IκBα degradation in RAW264.7 macrophage-like cells; it induces apoptosis in human breast cancer SK-BR-3 cells and lung cancer cells; in vivo, it significantly reduces lung tumor number, size, and total tumor volume in female A/J mice treated with vinyl carbamate.